🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

INDEGENE LIMITED INDGN NIFTY_SMALLNSEPHARMA

Healthcare · Health Information Services · India
https://www.indegene.com

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

READ MORE ›
₹521.55
-11.34% 1Y

Market & Price

Market Cap
₹12,533.74 Cr
Current Price
₹521.55
High / Low (52W)
₹617.63 / ₹423.50
Beta
0.76

Valuation

Stock P/E
31.34
Industry PE
37.60
Forward P/E
19.71
PEG Ratio
-
Book Value
₹130.75
Price to Book
3.99
P/S
3.57
EV/EBITDA
18.06
Dividend Yield
0.38%

Profitability & Returns

ROCE
15.40%
ROE
13.94%
ROA
7.75%
Profit Margin
11.43%
Op Margin
12.14%
EPS (Latest Qtr)
₹3.30
EPS (TTM)
₹16.64

Balance Sheet & Liquidity

Debt/Equity
4.60
Quick Ratio
2.27
Current Ratio
2.41
Debt
₹144.40 Cr
Total Assets
₹4,620.30 Cr
Current Assets
₹2,618.40 Cr
Working Capital
₹1,532.20 Cr

Ownership

Promoter Holding
57.07%
Chg in Prom Hold
-
FII / Inst Holding
20.45%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹11,183.34 Cr
Total Revenue (TTM)
₹3,510.50 Cr
EBITDA
₹619.10 Cr
Free Cash Flow
₹643.81 Cr
Operating Cash Flow
₹650.80 Cr
Shares Outstanding
₹24.03 Cr
Gross Margin
100.00%
Payout Ratio
12.03%

Growth (CAGR)

Revenue 5Y
15.04%
Profit 5Y
14.66%
Revenue (YoY)
32.80%
Earnings (YoY)
-32.30%

PROS

  • Compounding revenue at 15.0% over 5 years.
  • Profit CAGR of 14.7% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 INDGN INDEGENE LIMITED NIFTY_SMALLNSEPHARMA 521.55 31.34 ₹12,533.74 Cr 0.38% 15.40% 13.94% 15.04% 14.66%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue -720.40 Cr755.60 Cr760.80 Cr942.10 Cr1,003.40 Cr
Cost of Revenue ------
Gross Profit ------
Operating Expenses -608.60 Cr628.80 Cr627.10 Cr822.20 Cr881.60 Cr
Operating Income -111.80 Cr126.80 Cr133.70 Cr119.90 Cr121.80 Cr
EBITDA -169.50 Cr173.10 Cr177.40 Cr178.90 Cr154.10 Cr
Interest Expense -3.20 Cr3.10 Cr3.70 Cr4.60 Cr7.20 Cr
Pretax Income -146.30 Cr149.30 Cr152.10 Cr134.70 Cr105.10 Cr
Tax Provision -36.60 Cr31.70 Cr35.70 Cr31.80 Cr25.40 Cr
Net Income -109.70 Cr117.60 Cr116.40 Cr102.90 Cr79.70 Cr
Diluted EPS -4.554.884.824.263.30

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -2,306.10 Cr2,589.60 Cr2,839.30 Cr3,510.50 Cr
Cost of Revenue -----
Gross Profit -----
Operating Expenses -1,969.80 Cr2,154.80 Cr2,385.20 Cr3,017.90 Cr
Operating Income -336.30 Cr434.80 Cr454.10 Cr492.60 Cr
EBITDA -454.10 Cr581.00 Cr641.50 Cr670.80 Cr
Interest Expense -31.30 Cr46.30 Cr22.00 Cr19.30 Cr
Pretax Income -363.00 Cr458.60 Cr539.30 Cr525.00 Cr
Tax Provision -96.90 Cr121.90 Cr132.60 Cr123.90 Cr
Net Income -266.10 Cr336.70 Cr406.70 Cr401.10 Cr
Diluted EPS -11.1214.0917.0216.62

Compounded Sales Growth

5 Years:15.04%
1 Year:32.80%

Compounded Profit Growth

5 Years:14.66%
1 Year:-32.30%

Stock Price Performance

1 Year:-11.34%
6 Months:+1.41%
3 Months:+7.94%
1 Month:+5.27%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -2,203.87 Cr2,545.60 Cr3,325.90 Cr4,620.30 Cr
Current Assets -1,448.71 Cr1,790.80 Cr2,530.00 Cr2,618.40 Cr
Cash & Equivalents -73.58 Cr188.60 Cr241.00 Cr300.80 Cr
Inventory -----
Receivables -519.89 Cr555.70 Cr632.20 Cr770.20 Cr
Total Liabilities -1,140.14 Cr1,116.50 Cr710.30 Cr1,481.60 Cr
Current Liabilities -489.15 Cr610.90 Cr564.50 Cr1,086.20 Cr
Long Term Debt 10.94 Cr394.34 Cr333.40 Cr0-
Total Debt -502.58 Cr489.60 Cr101.60 Cr144.40 Cr
Total Equity -1,063.72 Cr1,429.10 Cr2,615.60 Cr3,138.70 Cr
Shares Outstanding -23.89 Cr23.93 Cr24.00 Cr24.03 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -130.20 Cr507.70 Cr441.90 Cr650.80 Cr
Investing Cash Flow --893.30 Cr-327.20 Cr-682.70 Cr-512.40 Cr
Financing Cash Flow -333.10 Cr-66.20 Cr287.50 Cr-82.60 Cr
Capital Expenditure --18.80 Cr-10.70 Cr-30.00 Cr-44.40 Cr
Free Cash Flow -111.40 Cr497.00 Cr411.90 Cr606.40 Cr
Net Change in Cash --430.00 Cr114.30 Cr46.70 Cr55.80 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----
Operating Margin % -14.6%16.8%16.0%14.0%
Net Margin % -11.5%13.0%14.3%11.4%
ROE % -25.0%23.6%15.5%12.8%
ROCE % -19.6%22.5%16.4%13.9%

Shareholding Pattern

Insiders
57.07%
Institutions
20.45%
Public Float
47.64%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for INDGN

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space